Denmark vs Fiji: The number of people with susceptibility test result for rifampicin
Denmark
113
in 2021
Fiji
127
in 2021
Denmark rank
106th
Fiji rank
105th
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Fiji
How they compare
Fiji currently reports 127 against 113 in Denmark, a difference of 14.
That makes Fiji's figure about 1.1 times Denmark's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Denmark ahead.
Denmark ranks 106th and Fiji ranks 105th of 155 countries.
Across the 2 decades both report, Denmark averaged higher in 1 and Fiji in 1.
Head to head by decade
| Decade | Denmark | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 162 | 139 | 23 | Denmark |
| 2020s | 120.5 | 123.5 | 3 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Fiji?
- Fiji, at 127 against 113 in Denmark as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Fiji?
- 14, with Fiji ahead.
- How many years of comparable data are there for Denmark and Fiji?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Fiji rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 106th and Fiji ranks 105th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.